PIRAMAL PHARMA
|
The Current P/S Ratio of PIRAMAL PHARMA is 2.84.
| Share Price | ₹196.5 | Oct 08,2026 |
| Market Cap | ₹26,153.4 Cr | |
| Sales-TTM | ₹9,205.3 Cr | TTM-Consolidated Results |
| Price/Sales | 2.84x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of PIRAMAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹26,153.4 Cr] as on Oct 08,2026
(/) Sales [ ₹9,205.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.84x ]
Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '2.84 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PIRAMAL PHARMA !
The chart below summarizes the trend in P/S Ratio of PIRAMAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of PIRAMAL PHARMA
PS Ratio Performance Analysis for PIRAMAL PHARMA
- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.71x.
- PIRAMAL PHARMA 's operated at median p/e ratio of 2.04x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2025 at 3.25x.
- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does PIRAMAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| PIRAMAL PHARMA | 9,205.3 | 2.84 | 26,153.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.02 | 420,483.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.19 | 249,248.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.31 | 177,822.0 |
| CIPLA LTD | 28,324.4 | 3.72 | 105,427.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.96 | 98,492.3 |
| MANKIND PHARMA LTD | 14,737.9 | 6.72 | 99,064.7 |
| LUPIN LTD | 29,966.6 | 2.96 | 88,805.7 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.89 | 111,242.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.70 | 94,477.0 |
| LAURUS LABS LTD | 7,269.6 | 14.86 | 108,062.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PIRAMAL PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.70x |
| Max industry PS | 22.19x |
| Median industry PS | 3.89x |
| Average industry PS | 7.38x |
You may also like the below Video Courses